Press for Imprivata
The Zurich Insurance fine that was issued earlier this week has caused much debate on data loss and protection. Omar Hussain, CEO of Imprivata, looks at the issues created because of it. Despite extensive legislation designed to safeguard sensitive information, data losses and unauthorised access to intellectual property are still worryingly commonplace. Consequently, organisations need to have more control and visibility over who is accessing data and where it is being stored.
Imprivata®, Inc., the company that simplifies and secures user access, today announced the formation of its Healthcare Advisory Board. This board draws upon real-world perspectives of industry leaders to address healthcare IT challenges and trends as the company develops innovative and practical solutions that solve the unique challenges facing the healthcare industry. Chaired by Barry P. Chaiken, MD, MPH, FHIMSS, chief medical officer of Imprivata, the Healthcare Advisory Board is comprised of Imprivata customers and industry experts, including:
Imprivata®, Inc. announced that St Andrew’s Healthcare, the UK’s largest not-for-profit mental health charity has selected Imprivata OneSign to provide 3,500 employees with faster and more efficient access to a range of applications via Single Sign-On (SSO) and strong authentication with smart cards. The rollout, completed in June 2010 across the organisation’s four sites in Basildon, Birmingham, Mansfield and Northampton will allow clinical and support staff to increase the speed at which they can securely access patient information and raise the levels of patient care
Imprivata®, Inc., the company that simplifies and secures access to patient information, today announced the results of its third annual online national survey that examines IT trends in healthcare. The 2010 Healthcare IT Survey polled hospitals across North America for input on securing patient health information, the move to electronic medical records (EMR) and the impact of clinician workflows on patient outcomes.